- ISIN
- IL0011326795
- CUSIP
- 001132679
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Jun 26, 2020
Highlights
- Market Cap
- $112.47M
- Enterprise Value
- $107.69M
- EPS (TTM)
- -$1.78
- EBITDA (TTM)
- -$32.72M
- Year Range
- $3.06 - $5.21
- Target Price
- $9.50
- ROA (TTM)
- -175.52%
- ROE (TTM)
- -383.02%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
PYPD Performance Chart
PolyPid Ltd. (PYPD) is up 18.2% since the beginning of the year. At $5 per share, PYPD is trading just below its 52-week high of $5. Investors who bought $1,000 worth of PYPD shares 5 years ago would now be looking at an investment worth $19.
Loading charts...
Returns By Period
PolyPid Ltd. (PYPD) has returned 18.20% so far this year and 56.40% over the past 12 months.
PolyPid Ltd.
- 1D
- 8.23%
- 1M
- 2.19%
- YTD
- 18.20%
- 6M
- 29.06%
- 1Y
- 56.40%
- 3Y*
- -21.99%
- 5Y*
- -54.68%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
PYPD Monthly Returns History
Based on dividend-adjusted daily data since Jun 26, 2020, PYPD's average daily return is -0.15%, while the average monthly return is -3.78%.
Historically, 36% of months were positive and 64% were negative. The best month was Jan 2024 with a return of +65.8%, while the worst month was Sep 2022 at -80.6%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 9 months.
On a daily basis, PYPD closed higher 44% of trading days. The best single day was Sep 12, 2022 with a return of +58.3%, while the worst single day was Sep 2, 2022 at -73.5%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 5.53% | -7.21% | 3.06% | 2.74% | 4.89% | 8.69% | 18.20% | ||||||
| 2025 | -5.92% | 12.94% | -16.10% | 5.17% | -1.75% | 26.07% | -4.82% | -0.30% | -0.45% | 14.84% | 3.14% | 9.87% | 42.76% |
| 2024 | 65.79% | -14.92% | -14.18% | 3.74% | -5.70% | -4.44% | -16.05% | -1.66% | -3.10% | -6.98% | 4.37% | -8.98% | -20.00% |
| 2023 | 10.11% | -12.76% | -31.34% | -8.67% | -7.16% | -6.41% | -1.37% | -16.67% | -49.89% | -8.20% | 13.53% | -19.15% | -81.84% |
| 2022 | -22.30% | -9.42% | 35.15% | -11.17% | 10.93% | -13.75% | 8.84% | 19.21% | -80.56% | -21.37% | -14.14% | -11.70% | -87.85% |
| 2021 | -5.15% | 18.85% | -17.92% | 0.44% | 3.26% | -4.68% | -9.77% | 16.03% | -17.93% | -8.61% | -4.36% | -15.59% | -42.02% |
Benchmark Metrics
PolyPid Ltd. has an annualized alpha of -37.96%, beta of 0.68, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since June 26, 2020.
- This stock participated in 230.48% of S&P 500 Index downside but only -30.81% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.68 may look defensive, but with R2 of 0.02 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -37.96%
- Beta
- 0.68
- R²
- 0.02
- Upside Capture
- -30.81%
- Downside Capture
- 230.48%
Return for Risk
Risk / Return Rank
PYPD ranks 79 for risk / return — better than 79% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for PolyPid Ltd. (PYPD) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PYPD | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.75 | ||
| Sortino ratioReturn per unit of downside risk | -0.72 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.37 | -0.13 |
| Calmar ratioReturn relative to maximum drawdown | 3.31 | 2.78 | +0.53 |
| Martin ratioReturn relative to average drawdown | 6.71 | 12.44 | -5.73 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the PolyPid Ltd.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the PolyPid Ltd. was 99.58%, occurring on Apr 7, 2025. The portfolio has not yet recovered.
The current PolyPid Ltd. drawdown is 99.10%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 selloff2025 | -99.58%Apr 2025 | 4y 9mo | — | 5y 12moJun 2020 - now |
Drawdown Indicators
| PYPD | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.58% | -56.78% | -42.80% |
Max Drawdown (1Y)Largest decline over 1 year | -17.11% | -9.10% | -8.01% |
Max Drawdown (3Y)Largest decline over 3 years | -80.39% | -18.90% | -61.49% |
Max Drawdown (5Y)Largest decline over 5 years | -99.16% | -25.43% | -73.73% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -99.10% | -1.80% | -97.30% |
Average DrawdownAverage peak-to-trough decline | -82.65% | -10.71% | -71.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.43% | 2.03% | +6.40% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of PolyPid Ltd. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how PolyPid Ltd. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PYPD in comparison with other companies in the Biotechnology industry. Currently, PYPD has a P/B value of 12.8. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with PYPD
Add PolyPid Ltd. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with PYPD